New Jersey Urology Appoints Senior Vice President of Clinical Research

11 Jun 2019 News

Urology Management Associates (UMA) has appointed Derek Grimes as Senior Vice President of Clinical Research at New Jersey Urology (NJU).

In this new role, Mr. Grimes will lead NJU’s Clinical Research Organization (CRO) and oversee operational site functions, profit and loss, clinical management and recruitment. He will also be responsible for managing and supporting client relationships in the pharmaceutical, biotech and medical device industries.

By growing our research capabilities at NJU, our patients and investigators will have greater access to potential new treatment options for urologic diseases, including prostate, bladder and kidney cancer. This will also help our physicians discover new ways to detect, diagnose, and reduce the risk of urologic disease. The goal of the CRO at NJU is to provide our patients with the most comprehensive approach to urology with the best access to care possible.

Prior to joining NJU in April, Mr. Grimes spent nearly twelve years with TKL Research in New Jersey serving as the Vice President of Clinical Operations, where he oversaw the Research Clinics division. He also spent eight years with Columbia and New York Universities managing and developing clinical trials for the universities.

Mr. Grimes holds a Bachelor of Science in Health Administration from St. Joseph’s College in Brooklyn, NY.

NJU Takes the Fuego Box Choco Challenge for Prostate Cancer

25 Mar 2019 News

Dr. Adam Perzin and members of New Jersey Urology’s clinical and administrative team took the Fuego Box Choco Challenge to help support the fight against prostate cancer – watch the video on our Facebook page!

The challenge is simple – purchase a Fuego Box Coco Loco spicy chocolate bar and eat as much as you can – while filming it. For every bar purchased, Fuego Box will donate $5.00 to prostate cancer research.

You can take the challenge, too! Visit: https://www.fuegobox.com/pages/choco_challenge to learn more.

Join NJU for a Tee-Off Against Prostate Cancer

13 Mar 2019 News

New Jersey Urology is once again proud to sponsor the Tee-Off Against Prostate Cancer event at TopGolf in Edison, NJ. All proceeds will benefit ZERO – The End of Prostate Cancer.

When: Sunday, March 24th | 2 p.m.
Where: TopGolf Edison (1013 U.S. Route 1, Edison, NJ 08817)

Get your friends, family, and co-workers together for a great time at TopGolf and help us put an end to prostate cancer! Enjoy three hours of play, an All-American buffet with beer and wine, and take home a swag bag of goodies! Form a team of six players or register as an individual and be assigned to a team.

The funds raised from the Tee-Off Against Prostate Cancer event are invested around the country to provide research for new prostate cancer treatments, free prostate cancer testing, and education for men and families about prostate cancer. No other prostate cancer charity spends more per dollar on programs – more than 85 cents. ZERO puts every donation to good use!

REGISTER HERE

J.W. Childs Appoints Scott Ciccarelli as CEO of Urology Management Associates

13 Dec 2018 News

New Jersey Urology (“NJU”) the leading urology service provider in New Jersey and J.W. Childs Associates (“JWC”), a leading middle-market private equity firm has appointed Scott Ciccarelli as the Chief Executive Officer to the recently formed Urology Management Associates (“UMA”) that provides administrative services to NJU.

“Scott joining is a critical step in the future of UMA and NJU as we strengthen our team to further grow and develop our leading urology centered group,” said Adam Suttin, Managing Partner of JWC.

The partnership between NJU and J.W. Childs represents a unique opportunity to combine the clinical leadership from NJU with the capital and strategic business expertise from J.W. Childs to position the organization for growth and success.

“Our goal is to enable physicians to focus on the delivery of transformative urological care with exceptional outcomes, patient satisfaction, and health cost certainty,” said Ciccarelli, CEO of UMA. “I am honored to be joining the premier physician urology group in the U.S. and look forward to the opportunity of working collaboratively with both the physicians and the UMA team to build a best-in-class management services organization (MSO).”

Scott is an accomplished executive with more than 25 years of experience gained at SRS Health, GE and Meridian Medical Management, with proven operations execution and leadership. In his most recent role, Scott served as President and CEO of SRS Health, a company that provides services and solutions to high volume surgical specialties.

Scott’s background in EHR/PM/RCM will be essential in helping to choose an appropriate IT system for NJU that will drive clinical and operational excellence. The plan includes leveraging his background in outcomes and patient engagement to help advance NJU’s mission – providing high quality urologic care that is comprehensive, compassionate, coordinated, innovative, and accessible to the patients and facilities they serve.

NJU Physicians Selected as New Jersey Monthly’s 2018 Jersey Choice Top Doctors

27 Nov 2018 News

We’re proud to announce that several New Jersey Urology physicians have been named New Jersey Monthly’s 2018 Jersey Choice Top Doctors. More than 24,000 New Jersey doctors were polled on which of their fellow practitioners they consider New Jersey’s best, resulting in the state’s 1,077 Top Doctors, as chosen by their peers.

New Jersey Monthly 2018 Jersey Choice Top Doctors:

View the complete list here >

NJU Physicians Selected as SJ Mag 2018 Top Docs

13 Nov 2018 News

We’re proud to announce that three New Jersey Urology (formerly Delaware Valley Urology) physicians have been named SJ Mag 2018 Top Docs. Two of our physicians were chosen by South Jersey doctors, who were asked to nominate doctors they would recommend to their family members. One of our physicians was nominated by SJ Mag’s readers, who were asked to nominate physicians who they think are Top Docs.

SJ Mag 2018 Top Docs (chosen by South Jersey doctors):

2018 Top Doc Patient Poll (chosen by SJ Mag readers):

Read SJ Mag’s complete list here >

Dr. Scott Asroff Named Best of Burlington County 2018

2 Oct 2018 News

We’re pleased to announce that Scott W. Asroff, MDhas been named a 2018 Best of Burlington County winner by the Burlington County Times.

Honored as an Industry Leader, Dr. Asroff was named “Best Of” in Urology for 2018.  Read the complete list >

The Best of Burlington County is a list, compiled annually, of readers’ favorite businesses, products, and services in the community. More than 130,000 reader votes were cast in 2018.

Dr. Asroff practices general urology, with special interest in male reproductive health, stone disease, and urologic cancers. He practices in BordentownMount Laurel and Willingboro.

To make an appointment, please call 877-388-2778.

J.W. Childs Associates Forms Urology Management Associates with New Jersey Urology

5 Sep 2018 News

New Jersey Urology (NJU), the leading urology service provider in New Jersey, and J.W. Childs Associates (JWC), a leading middle-market private equity firm, have formed Urology Management Associates (UMA) that will provide administrative services to NJU. The establishment of UMA enables NJU to continue to focus on providing world-class urology services while remaining a physician-led organization. UMA plans to partner with additional urology groups to provide administrative practice management services initially in the greater New York metropolitan area with long-range plans to expand nationally.

Recognizing the benefits of scale, NJU recently merged with Delaware Valley Urology (DVU) to become the leading provider of urology services in New Jersey and the largest single-specialty urology group in the U.S. NJU provides complete urologic care and comprehensive individualized treatment for its patients, including men’s health, women’s health and cancer care.

Dr. Lewis Gold and Dr. Mitchell Eisenberg, operating partners at JWC and former President and CEO of Sheridan Healthcare, respectively, will join the board of UMA along with Adam Suttin, Managing Partner, David Fiorentino, Partner and Jeff Miller, Principal. Dr. Gold commented, “We are very excited to collaborate with NJU to continue to develop and expand a best-in-class urology practice management organization.”

Dr. Martin Goldstein, who was appointed President of NJU and Senior Vice President of Corporate Development and Acquisitions of UMA said, “We look forward to working with J.W. Childs Associates on expanding business opportunities for UMA while maintaining NJU’s medical practice independence. JWC’s expertise in managing large-scale practices and UMA’s ability to handle the significant administrative burden of NJU’s non-clinical operations will enable NJU and its physicians to continue to focus on high-quality clinical care to meet the demands of our patients.” Victor Houtz who has been the COO of NJU since 2009 has been named COO at UMA.

The Bloom Organization negotiated on behalf of the NJU and DVU physicians. Mr. Henry Bloom, the founder of The Bloom Organization, said, “Forming UMA shortly after the consummation of the NJU and DVU merger took an incredible effort from all parties and I commend everyone involved. I have represented physicians for the last 30 years and I believe that the growth potential for physician services is better now than I have ever seen. We found a great partner in JWC and its operating executives. I am excited to see this organization execute on its growth strategy in the coming years.”

J.W. Childs Associates is a Boston-based private equity firm focused on investing in middle-market growth companies. Since inception in 1995, JWC has invested $3.7 billion of equity capital in 50 companies across the healthcare, consumer, and specialty retail/e-commerce industries. The firm’s success has been built on its industry focus and the extensive operating expertise of its partners.

The Bloom Organization advised NJU on the transaction with DLA Piper LLP serving as its legal counsel. McDermott Will & Emery LLP advised J.W. Childs.

Join NJU for a ZERO Prostate Cancer Run/Walk this Fall

22 Aug 2018 News

New Jersey Urology is proud to present South Jersey’s ZERO Prostate Cancer Run/Walk to help end prostate cancer.

When: Sunday, November 4th | 9 a.m.
Where: Valenzano Winery (1090 Route 206, Shamong, NJ 08088)

The 2018 ZERO Prostate Cancer Run/Walk – South Jersey features a 5K run/walk, 1-mile walk, Kids’ Superhero Dash for Dad, and virtual Snooze for Dudes program. Stick around for the family-friendly post-race celebration. Run/walk participants will receive shirts, free food and prizes, and the opportunity to connect with others who are impacted by prostate cancer. 5K and 1 Mile participants 21 and over (must show valid id) will receive a free wine glass and wine on race day.

The funds raised from 2018 ZERO Prostate Cancer Run/Walk – South Jersey are invested around the country to provide research for new prostate cancer treatments, free prostate cancer testing, and education for men and families about prostate cancer. No other prostate cancer charity spends more per dollar on programs – more than 85 cents. ZERO puts every donation to good use.

REGISTER HERE

NJU Physicians Selected as South Jersey Magazine 2018 Top Physicians

10 Aug 2018 News

We’re proud to announce that two New Jersey Urology (formerly Delaware Valley Urology) physicians have been honored as South Jersey Magazine 2018 Top Physicians. These physicians were chosen by South Jersey Magazine readers, who were asked to nominate doctors who made a lasting impact. South Jersey Magazine also asked area hospitals and medical providers to nominate a select group of doctors they feel are worthy of the spotlight because of their dedication to their patients and their commitment to advancing health care in South Jersey.

South Jersey Magazine 2018 Top Physicians:

Read South Jersey Magazine’s complete list here >

1 2

Search

+
Skip to content